- Filed
- Mar 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q2 2025 · Jan 31, 2025 | $20.05M |
| Cash And Equivalents | Q2 2025 · Jul 31, 2024 | $20M |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $7.17M |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $6.25M |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $8.89M |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $7.3M |
| Current Assets | Q2 2025 · Jan 31, 2025 | $24M |
| Current Assets | Q2 2025 · Jul 31, 2024 | $24M |
| Total Assets | Q2 2025 · Jan 31, 2025 | $37.09M |
| Total Assets | Q2 2025 · Jul 31, 2024 | $38.2M |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 14.07M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 14.02M sh |
| Stock Repurchased | Q2 2025 · Jan 31, 2024 | $13K |
| Capex | Q2 2025 · Jan 31, 2024 | $23K |
| Operating Cash Flow | Q2 2025 · Jan 31, 2024 | $2.81M |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | $30.68M |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | $38.98M |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $38.86M |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.66 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.66 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | −$0.66 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | −$0.66 |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $6.52M |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $12.02M |
| Net Income | Q2 2025 · Jan 31, 2024 | −$9.23M |
| Net Income | Q2 2025 · Jan 31, 2024 | −$9.25M |
| Net Income | Q2 2025 · Oct 31, 2023 | −$15K |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$11.93M |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$11.61M |
| Revenue | Q2 2025 · Jan 31, 2024 | $7.77M |
| Revenue | Q2 2025 · Jan 31, 2024 | $14.85M |